Edward Tobinick MD Blog

Comments: 0

Rapid improvement in stroke pain after treatment by Edward Tobinick, M.D.

Perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, March 2020.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Thursday, March 19, 2020 at 4:15 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Post Stroke Pain, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

4 yrs. after stroke, improvements in chronic pain & swallowing after treatment by Edward Tobinick, M.D.

4 years after brainstem stroke, improvements in chronic central post-stroke pain and less difficulty in swallowing immediately following perispinal etanercept treatment by Dr. Tobinick, February 28, 2020.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Friday, March 6, 2020 at 5:37 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, central post-stroke pain, CPSP, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Post Stroke Pain, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

From wheelchair to walking unassisted after treatment by Edward Tobinick, M.D., 2 yrs after stroke

Able to walk unassisted two years after stroke following perispinal etanercept treatment by Dr. Tobinick in November 2019. Sustained improvement in vision, spasticity, speech, balance, and walking documented 3 months after treatment when interviewed in February 2020 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Thursday, March 5, 2020 at 2:57 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Taste returns 10 months post-stroke following treatment by Edward Tobinick, M.D.

Taste was lost for 10 months until perispinal etanercept treatment by Dr. Tobinick on February 21, 2020. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.

Posted by INR PLLC on Wednesday, March 4, 2020 at 5:37 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Progressive improvement 5 years after cardiac arrest after treatment by Edward Tobinick, M.D.

Progressive improvements in speech and cognition after perispinal etanercept treatment by Dr. Tobinick 5 years after cardiac arrest. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, February 10, 2020.

Posted by INR PLLC on Tuesday, February 18, 2020 at 5:37 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #cardiac arrest, #stroke breakthrough, Aphasia, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

About Dr. Tobinick

Edward Lewis Tobinick is an American physician who is the inventor of the perispinal etanercept treatment for chronic stroke pain whose efficacy has been established by a randomized, double-blind, placebo-controlled clinical trial published in January 2020.

Dr. Tobinick graduated Phi Beta Kappa and Magna Cum Laude with honors in biology from Brandeis University in Waltham, Massachusetts and received his M.D. from the University of California San Diego School of Medicine in La Jolla, California.

The published scientific articles documenting unprecedented neurological effects produced by the novel method of drug delivery invented by Dr. Tobinick have been cited by hundreds of scientists from academic centers around the world.

Dr. Tobinick's breakthrough stroke treatment has been used to treat patients from every continent in the world, including from the U.S., Canada, England, Scotland, Wales, Ireland, Mexico, Trinidad, Jamaica, Haiti, Bahamas, Guatemala, Belize, Brazil, Columbia, Bolivia, Uruguay, Ecuador, Chile, Peru, Germany, France, Spain, Italy, Portugal, Belgium, Netherlands, Switzerland, Bulgaria, Romania, Ukraine, Poland, Denmark, Sweden, Norway, Iceland, Gibraltar, Uzbekistan, Turkey, Israel, Saudi Arabia, UAE, Oman, Iraq, Egypt, Morocco, Nigeria, Ghana, Cameroon, South Africa, Mozambique, Kenya, Mauritius, India, Bangladesh, Thailand, Vietnam, China, Hong Kong, Japan, Indonesia, Malaysia, Philippines, Australia, New Zealand, Papua New Guinea, Fiji, and the Cook Islands.

In 2018 the Australian Minister of Health, Hon. Greg Hunt, designated substantial funds to study Dr. Tobinick's breakthrough stroke treatment in Australia.

Dr. Tobinick has been an invited ad hoc reviewer for the journals Brain Research, Clinical Drug Investigation, CNS Drugs, Current Alzheimer Research, Experimental Neurology, Future Neurology, Journal of Neurochemistry, Journal of Neuroimmunology, Neuroscience, and Pharmaceutical Medicine and a member of the Editorial Board of the Journal of Neuroinflammation.

More Info